Skip navigation
Please use this identifier to cite or link to this item: https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/316
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPan, B.-
dc.contributor.authorAherne, N.-
dc.contributor.authorShakespeare, T.-
dc.contributor.authorGrossmann, M.-
dc.contributor.authorWong, P.-
dc.date.accessioned2024-12-17T03:46:19Z-
dc.date.available2024-12-17T03:46:19Z-
dc.date.issued2020-
dc.identifier.citationInternal Medicine Journal. 2020. 50:8.en
dc.identifier.urihttps://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/316-
dc.description.abstractNo abstract available.en
dc.language.isoenen
dc.subjectAbsorptiometric, Photonen
dc.subjectProstatic Neoplasmsen
dc.subjectAndrogen Antagonistsen
dc.titleBone health assessment by dual X-ray absorptiometry (DXA) scan in men commencing adjuvant androgen deprivation therapy (ADT) for prostate cancer.en
dc.typeArticleen
dc.contributor.mnclhdauthorPan, Belinda-
dc.contributor.mnclhdauthorAherne, Noel-
dc.contributor.mnclhdauthorShakespeare, Thomas P.-
Appears in Collections:Oncology / Cancer

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing